Found: 64
Select item for more details and to access through your institution.
Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?
- Published in:
- Liver International, 2007, v. 27, n. 7, p. 938, doi. 10.1111/j.1478-3231.2007.01511.x
- By:
- Publication type:
- Article
Whole Body MRI in the Detection of Lymph Node Metastases in Patients with Testicular Germ Cell Cancer.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/life12020212
- By:
- Publication type:
- Article
Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1391408
- By:
- Publication type:
- Article
Case report: Multidrug resistant gestational trophoblastic neoplasia: focus on failure of immunotherapy and success of high-dose chemotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1391408
- By:
- Publication type:
- Article
Stage shift and relative survival for head and neck cancer during the 2020 COVID-19 pandemic: a population-based study of temporal trends.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1253968
- By:
- Publication type:
- Article
Liver Insufficiency due to Breast Cancer Metastases.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, p. 650, doi. 10.1245/s10434-013-3136-x
- By:
- Publication type:
- Article
Cancer risk in immune-mediated inflammatory diseases (IMID).
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-98
- By:
- Publication type:
- Article
Metastatic Castrate-resistant Prostate Cancer: When and How to Treat?
- Published in:
- Journal of OncoPathology, 2013, v. 1, n. 4, p. 33, doi. 10.13032/tjop.2052-5931.100052
- By:
- Publication type:
- Article
Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Tamoxifen and Ovarian Function.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066616
- By:
- Publication type:
- Article
Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2009, v. 266, n. 3, p. 437, doi. 10.1007/s00405-008-0767-9
- By:
- Publication type:
- Article
Activity of chemotherapy in the palliative treatment of salivary gland tumors: review of the literature.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2007, v. 264, n. 6, p. 587, doi. 10.1007/s00405-007-0297-x
- By:
- Publication type:
- Article
Epithelial–myoepithelial carcinoma of the submandibular gland with symptomatic lung metastases treated with chemotherapy.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2006, v. 263, n. 12, p. 1158, doi. 10.1007/s00405-006-0125-8
- By:
- Publication type:
- Article
Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2006, v. 263, n. 8, p. 786, doi. 10.1007/s00405-006-0060-8
- By:
- Publication type:
- Article
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03643-3
- By:
- Publication type:
- Article
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 261, doi. 10.1007/s00262-010-0935-9
- By:
- Publication type:
- Article
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2681, doi. 10.3390/cancers15102681
- By:
- Publication type:
- Article
Unmet Needs and Perspectives in Oral Cancer Prevention.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1815, doi. 10.3390/cancers14071815
- By:
- Publication type:
- Article
Vaccine-Based Immunotherapy for Head and Neck Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6041, doi. 10.3390/cancers13236041
- By:
- Publication type:
- Article
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5364, doi. 10.3390/cancers13215364
- By:
- Publication type:
- Article
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1251, doi. 10.3390/cancers13061251
- By:
- Publication type:
- Article
A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1425, doi. 10.3390/cancers12061425
- By:
- Publication type:
- Article
Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1207, doi. 10.1007/s10637-013-9933-z
- By:
- Publication type:
- Article
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 760, doi. 10.1007/s10637-012-9869-8
- By:
- Publication type:
- Article
Castrate-Resistant Prostate Cancer with Peritoneal Metastases Treated with Docetaxel-Based Chemotherapy.
- Published in:
- Urologia Internationalis, 2014, v. 93, n. 1, p. 49, doi. 10.1159/000354396
- By:
- Publication type:
- Article
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.730785
- By:
- Publication type:
- Article
Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0225748
- By:
- Publication type:
- Article
Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 12, p. 3472, doi. 10.1002/ccr3.3434
- By:
- Publication type:
- Article
HER2 as a Predictive Biomarker and Treatment Target in Colorectal Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified 'all-in-one' imaging approach?
- Published in:
- Prostate, 2014, v. 74, n. 5, p. 469, doi. 10.1002/pros.22764
- By:
- Publication type:
- Article
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase I study of volasertib combined with afatinib, in advanced solid tumors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 729, doi. 10.1007/s00280-014-2554-1
- By:
- Publication type:
- Article
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 6, p. 1241, doi. 10.1007/s00280-014-2460-6
- By:
- Publication type:
- Article
Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 2, p. 293, doi. 10.1007/s00280-012-1914-y
- By:
- Publication type:
- Article
Phase II study of dual phosphoinositol-3-kinase ( PI3K) and mammalian target of rapamycin ( mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma.
- Published in:
- BJU International, 2016, v. 118, n. 3, p. 408, doi. 10.1111/bju.13415
- By:
- Publication type:
- Article
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2015, v. 115, n. 5, p. 744, doi. 10.1111/bju.12845
- By:
- Publication type:
- Article
Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00155
- By:
- Publication type:
- Article
Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
- Published in:
- Urologia Internationalis, 2018, v. 100, n. 3, p. 357, doi. 10.1159/000443970
- By:
- Publication type:
- Article
Tubulocystic Carcinoma of the Kidney with Fatal Outcome in an Adolescent Male.
- Published in:
- Urologia Internationalis, 2015, v. 94, n. 4, p. 485, doi. 10.1159/000366287
- By:
- Publication type:
- Article
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
- Published in:
- Head & Neck, 2020, v. 42, n. 11, p. 3141, doi. 10.1002/hed.26363
- By:
- Publication type:
- Article
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 2, p. 181, doi. 10.1007/s11523-023-00948-8
- By:
- Publication type:
- Article
Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer.
- Published in:
- Targeted Oncology, 2015, v. 10, n. 3, p. 375, doi. 10.1007/s11523-014-0342-9
- By:
- Publication type:
- Article
Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Single-arm, Multicenter, Open-label Phase 2 Study of Lapatinib as the Second-line Treatment of Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 13, p. 2881, doi. 10.1002/cncr.24337
- By:
- Publication type:
- Article
Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB).
- Published in:
- Oncology, 2013, v. 85, n. 4, p. 208, doi. 10.1159/000354085
- By:
- Publication type:
- Article
Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
- Published in:
- Oncologist, 2022, v. 27, n. 10, p. e783, doi. 10.1093/oncolo/oyac172
- By:
- Publication type:
- Article